Bitte aktiviere Javascript und schalte etwaige Werbeblocker ab

Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

News und Analysen

EQS-News: Nemetschek Group Completes Acquisition of GoCanvas Holdings, Inc. : http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24062/Nemetschek_AG_Logo.svg.png

EQS-News: Nemetschek Group Completes Acquisition of GoCanvas Holdings, Inc.

EQS-News: Nemetschek Group Completes Acquisition of GoCanvas Holdings, Inc.

0

EQS-Adhoc: CANCOM SE resolves to cancel the acquired 1,669,758 treasury shares together with a capital reduction and a public share buyback offer at a price of € 33.00 per share: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24051/375px-PLAN._BUILT._PERFORM..png

EQS-Adhoc: CANCOM SE resolves to cancel the acquired 1,669,758 treasury shares together with a capital reduction and a public share buyback offer at a price of € 33.00 per share

EQS-Adhoc: CANCOM SE resolves to cancel the acquired 1,669,758 treasury shares together with a capital reduction and a public share buyback offer at a price of € 33.00 per share

0

EQS-News: Nagarro SE: Nagarro’s Annual General Meeting of June 27, 2024, passes all resolutions and appoints KPMG as auditor: https://upload.wikimedia.org/wikipedia/commons/0/0a/Nagarro_Horizontal_Light_400x100px_300dpi.png

EQS-News: Nagarro SE: Nagarro’s Annual General Meeting of June 27, 2024, passes all resolutions and appoints KPMG as auditor

EQS-News: Nagarro SE: Nagarro’s Annual General Meeting of June 27, 2024, passes all resolutions and appoints KPMG as auditor

0

EQS-News: Just – Evotec Biologics selected by U.S. Department of Defense for Manufacturing Optimization Program: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23749/Evotec_high_res_logo_%28blue_and_grey%29.jpg

EQS-News: Just – Evotec Biologics selected by U.S. Department of Defense for Manufacturing Optimization Program

EQS-News: Just – Evotec Biologics selected by U.S. Department of Defense for Manufacturing Optimization Program

0

EQS-Adhoc: VARTA AG: VARTA AG adjusts revenue forecast for 2024 due to further slowdown in the energy storage market

EQS-Adhoc: VARTA AG: VARTA AG adjusts revenue forecast for 2024 due to further slowdown in the energy storage market

0

EQS-News: MorphoSys and Novartis Sign Delisting Agreement and Intend to Implement a Merger Squeeze-out of MorphoSys’ Minority Shareholders

EQS-News: MorphoSys and Novartis Sign Delisting Agreement and Intend to Implement a Merger Squeeze-out of MorphoSys’ Minority Shareholders

0

EQS-Adhoc: Ad hoc: Novartis BidCo Germany AG Intends to Implement a Merger Squeeze-out of MorphoSys AG’s Minority Shareholders

EQS-Adhoc: Ad hoc: Novartis BidCo Germany AG Intends to Implement a Merger Squeeze-out of MorphoSys AG’s Minority Shareholders

0

EQS-Adhoc: United Internet AG: Non-scheduled, non-cash impairment on Tele Columbus investment: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24075/330px-UnitedInternet_logo.svg.png

EQS-Adhoc: United Internet AG: Non-scheduled, non-cash impairment on Tele Columbus investment

EQS-Adhoc: United Internet AG: Non-scheduled, non-cash impairment on Tele Columbus investment

0

EQS-News: Evotec announces progress in neuroscience collaboration with Bristol Myers Squibb: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23749/Evotec_high_res_logo_%28blue_and_grey%29.jpg

EQS-News: Evotec announces progress in neuroscience collaboration with Bristol Myers Squibb

EQS-News: Evotec announces progress in neuroscience collaboration with Bristol Myers Squibb

0

EQS-News: Evotec SE: Results of the Annual General Meeting 2024: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23749/Evotec_high_res_logo_%28blue_and_grey%29.jpg

EQS-News: Evotec SE: Results of the Annual General Meeting 2024

EQS-News: Evotec SE: Results of the Annual General Meeting 2024

0

EQS-Adhoc: Ad hoc: Arkadius Pichota and Lukas Gilgen appointed to Management Board of MorphoSys AG replacing the current CEO and CFO

EQS-Adhoc: Ad hoc: Arkadius Pichota and Lukas Gilgen appointed to Management Board of MorphoSys AG replacing the current CEO and CFO

0

EQS-News: Annual General Meeting of CANCOM SE elects Supervisory Board and approves dividend of € 1.00: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24051/375px-PLAN._BUILT._PERFORM..png

EQS-News: Annual General Meeting of CANCOM SE elects Supervisory Board and approves dividend of € 1.00

EQS-News: Annual General Meeting of CANCOM SE elects Supervisory Board and approves dividend of € 1.00

0

EQS-News: Nemetschek Group to Acquire GoCanvas to further Accelerate Digitalization in Construction Industry: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24062/Nemetschek_AG_Logo.svg.png

EQS-News: Nemetschek Group to Acquire GoCanvas to further Accelerate Digitalization in Construction Industry

EQS-News: Nemetschek Group to Acquire GoCanvas to further Accelerate Digitalization in Construction Industry

0

EQS-Adhoc: Nemetschek SE to Acquire GoCanvas to further Accelerate Digitalization in Construction Industry: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24062/Nemetschek_AG_Logo.svg.png

EQS-Adhoc: Nemetschek SE to Acquire GoCanvas to further Accelerate Digitalization in Construction Industry

EQS-Adhoc: Nemetschek SE to Acquire GoCanvas to further Accelerate Digitalization in Construction Industry

0

EQS-News: Evotec, Inserm, Lille University Hospital and Inserm Transfert enter collaboration to identify novel therapeutic targets in obesity and metabolic diseases: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23749/Evotec_high_res_logo_%28blue_and_grey%29.jpg

EQS-News: Evotec, Inserm, Lille University Hospital and Inserm Transfert enter collaboration to identify novel therapeutic targets in obesity and metabolic diseases

EQS-News: Evotec, Inserm, Lille University Hospital and Inserm Transfert enter collaboration to identify novel therapeutic targets in obesity and metabolic diseases

0

EQS-News: Evotec and CHDI Foundation extend strategic drug discovery collaboration in Huntington’s disease : http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23749/Evotec_high_res_logo_%28blue_and_grey%29.jpg

EQS-News: Evotec and CHDI Foundation extend strategic drug discovery collaboration in Huntington’s disease

EQS-News: Evotec and CHDI Foundation extend strategic drug discovery collaboration in Huntington’s disease

0

EQS-News: Evotec reports Q1 2024 results and provides corporate update: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23749/Evotec_high_res_logo_%28blue_and_grey%29.jpg

EQS-News: Evotec reports Q1 2024 results and provides corporate update

EQS-News: Evotec reports Q1 2024 results and provides corporate update

0

EQS-News: freenet successfully starts 2024 - very dynamic growth in IPTV customers: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24058/375px-Freenet_AG_Logo.svg.png

EQS-News: freenet successfully starts 2024 - very dynamic growth in IPTV customers

EQS-News: freenet successfully starts 2024 - very dynamic growth in IPTV customers

0

EQS-News: Evotec SE to announce results for first quarter 2024 on 22 may 2024: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23749/Evotec_high_res_logo_%28blue_and_grey%29.jpg

EQS-News: Evotec SE to announce results for first quarter 2024 on 22 may 2024

EQS-News: Evotec SE to announce results for first quarter 2024 on 22 may 2024

0

EQS-News: CANCOM: CANCOM Group starts the 2024 financial year with significant growth: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24051/375px-PLAN._BUILT._PERFORM..png

EQS-News: CANCOM: CANCOM Group starts the 2024 financial year with significant growth

EQS-News: CANCOM: CANCOM Group starts the 2024 financial year with significant growth

0

EQS-News: Nagarro announces Q1 '24 results, posts profitable growth: https://upload.wikimedia.org/wikipedia/commons/0/0a/Nagarro_Horizontal_Light_400x100px_300dpi.png

EQS-News: Nagarro announces Q1 '24 results, posts profitable growth

EQS-News: Nagarro announces Q1 '24 results, posts profitable growth

0

EQS-News: Annual General Meeting approves dividend of EUR 1.20 per share : http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24068/Siltronic_Logo.svg.png

EQS-News: Annual General Meeting approves dividend of EUR 1.20 per share

EQS-News: Annual General Meeting approves dividend of EUR 1.20 per share

0

EQS-News: 1&1 AG: New consultation on spectrum allocation: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24057/Drillisch_AG_Logo.svg.png

EQS-News: 1&1 AG: New consultation on spectrum allocation

EQS-News: 1&1 AG: New consultation on spectrum allocation

0

EQS-News: freenet Annual General Meeting approves dividend increase of more than 5 %: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24058/375px-Freenet_AG_Logo.svg.png

EQS-News: freenet Annual General Meeting approves dividend increase of more than 5 %

EQS-News: freenet Annual General Meeting approves dividend increase of more than 5 %

0

EQS-News: 1&1 with a good start to the year : http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24057/Drillisch_AG_Logo.svg.png

EQS-News: 1&1 with a good start to the year

EQS-News: 1&1 with a good start to the year

0